On October 24, 2023, Vistagen Therapeutics, Inc. appointed Joshua Prince as the Chief Operating Officer. Mr. Prince, age 53, has served as the Company?s Senior Vice President, Business Operations, since November 2021. Mr. Prince has over 20 years of experience in the pharmaceutical industry.

Throughout his career, he has developed extensive expertise from early development through commercial launch of pharmaceuticals across a range of therapeutic areas. Prior to joining the Company, Mr. Prince held multiple positions at CSL Behring, Teva Pharmaceuticals, and AstraZeneca PLC, including North American Lead, Commercial Insight and Analytics, Senior Director of CNS Global Insight, and Director of Forecasting & Performance Analytics. Mr. Prince holds a BS in Mechanical Engineering from the University of Missouri-Rolla, and an MBA from The Pennsylvania State University.